JP2011522832A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522832A5
JP2011522832A5 JP2011512700A JP2011512700A JP2011522832A5 JP 2011522832 A5 JP2011522832 A5 JP 2011522832A5 JP 2011512700 A JP2011512700 A JP 2011512700A JP 2011512700 A JP2011512700 A JP 2011512700A JP 2011522832 A5 JP2011522832 A5 JP 2011522832A5
Authority
JP
Japan
Prior art keywords
antibody
fragment
therapeutic agent
dose
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011512700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522832A (ja
JP5607613B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/046441 external-priority patent/WO2009149370A1/en
Publication of JP2011522832A publication Critical patent/JP2011522832A/ja
Publication of JP2011522832A5 publication Critical patent/JP2011522832A5/ja
Application granted granted Critical
Publication of JP5607613B2 publication Critical patent/JP5607613B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011512700A 2008-06-06 2009-06-05 関節リウマチの治療のための方法 Expired - Fee Related JP5607613B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5971108P 2008-06-06 2008-06-06
US61/059,711 2008-06-06
US9523208P 2008-09-08 2008-09-08
US61/095,232 2008-09-08
PCT/US2009/046441 WO2009149370A1 (en) 2008-06-06 2009-06-05 Methods for the treatment of rheumatoid arthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014173653A Division JP5809338B2 (ja) 2008-06-06 2014-08-28 関節リウマチの治療のための方法

Publications (3)

Publication Number Publication Date
JP2011522832A JP2011522832A (ja) 2011-08-04
JP2011522832A5 true JP2011522832A5 (enExample) 2014-04-10
JP5607613B2 JP5607613B2 (ja) 2014-10-15

Family

ID=40983388

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011512700A Expired - Fee Related JP5607613B2 (ja) 2008-06-06 2009-06-05 関節リウマチの治療のための方法
JP2014173653A Expired - Fee Related JP5809338B2 (ja) 2008-06-06 2014-08-28 関節リウマチの治療のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014173653A Expired - Fee Related JP5809338B2 (ja) 2008-06-06 2014-08-28 関節リウマチの治療のための方法

Country Status (12)

Country Link
US (1) US20110189172A1 (enExample)
EP (1) EP2293816B1 (enExample)
JP (2) JP5607613B2 (enExample)
AU (1) AU2009256072B2 (enExample)
CA (1) CA2727171A1 (enExample)
CY (1) CY1113640T1 (enExample)
DK (1) DK2293816T3 (enExample)
ES (1) ES2398693T3 (enExample)
HR (1) HRP20130042T1 (enExample)
PL (1) PL2293816T3 (enExample)
PT (1) PT2293816E (enExample)
WO (1) WO2009149370A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
US20080269762A1 (en) * 2007-04-25 2008-10-30 Biomet Manufacturing Corp. Method and device for repair of cartilage defects
RU2018100129A (ru) 2007-12-20 2019-02-20 Ксома (Сша) Ллс Способы лечения подагры
US8753690B2 (en) * 2008-02-27 2014-06-17 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
JP5844258B2 (ja) 2009-08-27 2016-01-13 バイオメット、バイオロジクス、リミテッド、ライアビリティー、カンパニーＢｉｏｍｅｔ Ｂｉｏｌｏｇｉｃｓ， Ｌｌｃ インターロイキン−１受容体アンタゴニストの生産のための植込み型装置
US20110052561A1 (en) * 2009-08-27 2011-03-03 Biomet Biologics,LLC Osteolysis treatment
AU2011296356B2 (en) 2010-09-03 2015-07-09 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2012034039A2 (en) 2010-09-10 2012-03-15 Apexigen, Inc. Anti-il-1 beta antibodies and methods of use
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
CN104203979B (zh) * 2012-03-19 2017-08-08 法国国家健康医学研究院 用于动脉瘤的治疗或预防的方法和药物组合物
MX374817B (es) * 2012-11-05 2025-03-06 Delenex Therapeutics Ag Miembros de union para il-1 beta.
ES2895848T3 (es) 2012-12-17 2022-02-22 Cell Medica Inc Anticuerpos contra IL-1 beta
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
WO2015081253A1 (en) 2013-11-26 2015-06-04 Biomet Biologics, Llc Methods of mediating macrophage phenotypes
US10441635B2 (en) 2014-11-10 2019-10-15 Biomet Biologics, Llc Methods of treating pain using protein solutions
WO2016075035A1 (en) 2014-11-10 2016-05-19 F. Hoffmann-La Roche Ag Anti-ang2 antibodies and methods of use
JP2017537896A (ja) 2014-11-10 2017-12-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 二重特異性抗体及び眼科に使用する方法
US9763800B2 (en) 2015-03-18 2017-09-19 Biomet C. V. Implant configured for hammertoe and small bone fixation
CN113444177A (zh) * 2020-03-27 2021-09-28 中山康方生物医药有限公司 抗IL-1β的抗体、其药物组合物及其用途
CN115281149A (zh) * 2021-05-12 2022-11-04 四川大学华西医院 一种临床前类风湿关节炎(Pre-RA)小鼠模型

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US4762914A (en) * 1984-05-18 1988-08-09 Auron Philip E Truncated protein of interleukin-1
US5077219A (en) * 1984-05-18 1991-12-31 New England Medical Center Hospitals Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US5484887A (en) * 1984-06-19 1996-01-16 Immunex Corporation Homogeneous interleukin 1
US5122459A (en) * 1984-12-31 1992-06-16 Immunex Corporation Gene encoding biologically active human interleukin 1
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4935343A (en) * 1986-08-08 1990-06-19 Syntex (U.S.A.) Inc. Monoclonal antibodies for interleukin-1β
US5474899A (en) * 1987-05-13 1995-12-12 Cistron Biotechnology, Inc. Selective immunoassay for IL-1 β
DE68925935T2 (de) * 1988-10-01 1996-08-14 Otsuka Pharma Co Ltd Antikörper gegen Interleukin-1-beta
ATE165114T1 (de) * 1989-02-27 1998-05-15 New England Medical Center Inc Il-1, dessen biologische aktivität inhibiert ist
IE922437A1 (en) * 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
PT1024191E (pt) * 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
WO1993011794A1 (en) * 1991-12-13 1993-06-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
WO1994000470A1 (en) * 1992-06-30 1994-01-06 The Wistar Institute Of Anatomy And Biology DEVELOPMENTAL EMBRYONIC MOUSE cDNA LIBRARIES
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
GB0001448D0 (en) * 2000-01-21 2000-03-08 Novartis Ag Organic compounds
EP1282435A2 (en) * 2000-05-12 2003-02-12 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
GB0020685D0 (en) * 2000-08-22 2000-10-11 Novartis Ag Organic compounds
US20030026806A1 (en) * 2000-10-27 2003-02-06 Amgen Inc. Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
US20030166069A1 (en) * 2000-11-28 2003-09-04 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US6727234B2 (en) * 2001-04-03 2004-04-27 University Of Iowa Research Foundation Isoprenoid analog compounds and methods of making and use thereof
US20050075488A1 (en) * 2001-07-26 2005-04-07 Bright Stuart Willis Interleukin-1 beta antibodies
US20050152850A1 (en) * 2004-01-09 2005-07-14 Engebretson Steven P. Methods and compositions for facilitating metabolic control
US7732478B2 (en) * 2004-01-09 2010-06-08 The Trustees Of Columbia University In The City Of New York Methods for facilitating metabolic control
US8618054B2 (en) * 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
ES2335232T3 (es) * 2005-06-21 2010-03-23 Xoma Technology Ltd. Anticuerpos y fragmentos de los mismos que se unen a la il-1 beta.
CA2963828A1 (en) * 2005-10-26 2007-05-03 Novartis Ag Novel use of il-1beta compounds
WO2008077145A2 (en) * 2006-12-20 2008-06-26 Xoma Technology Ltd. Treatment of il-1-beta related diseases
RU2018100129A (ru) * 2007-12-20 2019-02-20 Ксома (Сша) Ллс Способы лечения подагры

Similar Documents

Publication Publication Date Title
JP2015007098A5 (enExample)
JP2014503482A5 (enExample)
Genovese et al. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
RU2018100129A (ru) Способы лечения подагры
JP2019088311A (ja) 抗ｉｌ−３３抗体及びその使用
JP2011507891A5 (enExample)
CN114286828A (zh) 针对靶向b细胞成熟抗原的多特异性抗体的给药方案和组合疗法
JP2017079785A5 (enExample)
CN104800844A (zh) 使用il-17拮抗剂治疗类风湿性关节炎的方法
JP6255099B2 (ja) Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法
JP6469012B2 (ja) インターロイキン−６に対する抗体およびその使用
JP2016528247A5 (enExample)
CN108310376A (zh) 用于治疗类风湿性关节炎的组合物及其使用方法
JP2013543501A5 (enExample)
RU2016136364A (ru) Способы лечения или предупреждения астмы посредством введения антагониста il-4r
JP2012021001A5 (enExample)
JP2016519650A5 (enExample)
JP2009511480A5 (enExample)
JP2018535948A (ja) レプチン受容体を活性化させる抗原結合タンパク質
JP2014114288A5 (enExample)
JP2014169326A5 (enExample)
RU2015114923A (ru) СПОСОБЫ ЛЕЧЕНИЯ IL-1β-ЗАВИСИМЫХ ЗАБОЛЕВАНИЙ
JP2013538796A5 (enExample)
RU2014117510A (ru) Лечение ревматоидного артрита
JP2013526485A5 (enExample)